Last reviewed · How we verify
starch tablets
Starch tablets provide a source of carbohydrates for nutritional supplementation or as a pharmaceutical excipient/filler.
Starch tablets provide a source of carbohydrates for nutritional supplementation or as a pharmaceutical excipient/filler. Used for Nutritional supplementation (if marketed as such).
At a glance
| Generic name | starch tablets |
|---|---|
| Also known as | placebo |
| Sponsor | Coordinación de Investigación en Salud, Mexico |
| Modality | Small molecule |
| Therapeutic area | Nutritional supplement / Pharmaceutical excipient |
| Phase | FDA-approved |
Mechanism of action
Starch is a polysaccharide that serves as an inert pharmaceutical ingredient commonly used as a binder, filler, or disintegrant in tablet formulations. When used as a standalone product, starch tablets may provide dietary carbohydrate supplementation. Starch itself has no direct pharmacological mechanism of action on disease pathways.
Approved indications
- Nutritional supplementation (if marketed as such)
Common side effects
- Gastrointestinal disturbance
- Allergic reaction (rare, if starch source is allergenic)
Key clinical trials
- The Effect of NP-2006 on Sleep Quality and Health (NA)
- Ademetionine in Obstructive Hypertrophic Cardiomyopathy (PHASE2)
- Effect of Vitamin D and Folic Acid on Mild Cognitive Impairment (NA)
- Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants (PHASE3)
- Clemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams Syndrome (PHASE2)
- Phase I Trial of Defactinib and VS-6766. (PHASE1)
- The Effect of Probiotic Supplementation on the Exercise Performance of Long-distance Runners. (NA)
- Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- starch tablets CI brief — competitive landscape report
- starch tablets updates RSS · CI watch RSS
- Coordinación de Investigación en Salud, Mexico portfolio CI